|
G |
Gna15 |
G protein subunit alpha 15 |
increases response to substance multiple interactions |
ISO |
GNA15 protein results in increased susceptibility to alpha-ionone [GNA15 protein results in increased susceptibility to alpha-ionone] which results in increased activity of OR1A1B protein |
CTD |
PMID:15598656 |
|
NCBI chr 7:8,184,632...8,205,508
Ensembl chr 7:8,184,861...8,205,508
|
|
G |
Olr59 |
olfactory receptor 59 |
decreases activity |
ISO |
alpha-ionone results in decreased activity of OR51E2 protein |
CTD |
PMID:27226631 |
|
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
|
|
|
G |
Calml5 |
calmodulin-like 5 |
increases expression |
ISO |
beta-damascenone results in increased expression of CALM4 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr17:66,394,433...66,395,352
|
|
G |
Casp14 |
caspase 14 |
increases expression affects localization |
ISO |
beta-damascenone results in increased expression of CASP14 mRNA beta-damascenone affects the localization of CASP14 protein |
CTD |
PMID:22982537 |
|
NCBI chr 7:10,929,759...10,932,591
Ensembl chr 7:10,926,725...10,933,405
|
|
G |
Ces3a |
carboxylesterase 3a |
increases expression |
ISO |
beta-damascenone results in increased expression of CES3 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Clca1 |
chloride channel accessory 1 |
increases expression |
ISO |
beta-damascenone results in increased expression of CLCA1 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
|
|
G |
Clca2 |
chloride channel accessory 2 |
increases expression |
ISO |
beta-damascenone results in increased expression of CLCA2 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 2:233,993,619...234,022,691
Ensembl chr 2:233,995,078...234,022,199
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
increases expression |
ISO |
beta-damascenone results in increased expression of CYP17A1 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Fcgbp |
Fc gamma binding protein |
increases expression |
ISO |
beta-damascenone results in increased expression of FCGBP mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 1:83,374,979...83,413,082
Ensembl chr 1:83,372,127...83,413,083
|
|
G |
Flg |
filaggrin |
increases expression |
ISO |
beta-damascenone results in increased expression of FLG mRNA; beta-damascenone results in increased expression of FLG protein |
CTD |
PMID:22982537 |
|
NCBI chr 2:178,884,793...178,912,986
|
|
G |
Hrnr |
hornerin |
increases expression |
ISO |
beta-damascenone results in increased expression of HRNR mRNA |
CTD |
PMID:22982537 |
|
|
|
G |
Il20ra |
interleukin 20 receptor subunit alpha |
increases expression |
ISO |
beta-damascenone results in increased expression of IL20RA mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 1:14,424,215...14,494,226
Ensembl chr 1:14,451,228...14,493,602
|
|
G |
Il36rn |
interleukin 36 receptor antagonist |
increases expression |
ISO |
beta-damascenone results in increased expression of IL36RN mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016
|
|
G |
Krt1 |
keratin 1 |
increases expression |
ISO |
beta-damascenone results in increased expression of KRT1 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
|
|
G |
Krt10 |
keratin 10 |
increases expression |
ISO |
beta-damascenone results in increased expression of KRT10 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
|
|
G |
Lce1b |
late cornified envelope 1B |
increases expression |
ISO |
beta-damascenone results in increased expression of LCE1B mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 2:178,255,351...178,257,533
Ensembl chr 2:178,256,213...178,257,985
|
|
G |
Lce1f |
late cornified envelope 1F |
increases expression |
ISO |
beta-damascenone results in increased expression of LCE1F mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 2:178,305,786...178,307,372
Ensembl chr 2:178,305,786...178,307,372
|
|
G |
Lipm |
lipase, family member M |
increases expression |
ISO |
beta-damascenone results in increased expression of LIPM mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 1:231,618,145...231,637,599
Ensembl chr 1:231,618,284...231,637,410
|
|
G |
Loricrin |
loricrin cornified envelope precursor protein |
increases expression |
ISO |
beta-damascenone results in increased expression of LORICRIN mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 2:177,558,062...177,560,960
Ensembl chr 2:177,558,252...177,559,807
|
|
G |
Otop3 |
otopetrin 3 |
increases expression |
ISO |
beta-damascenone results in increased expression of OTOP3 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr10:100,577,346...100,588,729
Ensembl chr10:100,577,392...100,588,726
|
|
G |
Pla2g4f |
phospholipase A2, group IVF |
increases expression |
ISO |
beta-damascenone results in increased expression of PLA2G4F mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 3:107,249,053...107,266,201
Ensembl chr 3:107,250,075...107,264,689
|
|
G |
Plcxd1 |
phosphatidylinositol-specific phospholipase C, X domain containing 1 |
increases expression |
ISO |
beta-damascenone results in increased expression of PLCXD1 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr12:46,578,917...46,582,181
Ensembl chr12:46,579,225...46,582,392
|
|
G |
Sdr16c5 |
short chain dehydrogenase/reductase family 16C, member 5 |
increases expression |
ISO |
beta-damascenone results in increased expression of SDR16C5 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 5:17,018,813...17,043,974
Ensembl chr 5:17,018,813...17,040,970
|
|
G |
Susd2 |
sushi domain containing 2 |
increases expression |
ISO |
beta-damascenone results in increased expression of SUSD2 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,017,477...13,024,903
|
|
G |
Tmprss4 |
transmembrane serine protease 4 |
increases expression |
ISO |
beta-damascenone results in increased expression of TMPRSS4 mRNA |
CTD |
PMID:22982537 |
|
NCBI chr 8:45,475,819...45,508,409
Ensembl chr 8:45,476,053...45,508,409
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
beta-ionone results in increased expression of BAX protein |
CTD |
PMID:31506784 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
beta-ionone results in decreased expression of BCL2 protein 3-methyladenine inhibits the reaction [beta-ionone results in decreased expression of BCL2 protein]; dorsomorphin inhibits the reaction [beta-ionone results in decreased expression of BCL2 protein]; Hydroxychloroquine inhibits the reaction [beta-ionone results in decreased expression of BCL2 protein]; STK11 protein affects the reaction [beta-ionone results in decreased expression of BCL2 protein] |
CTD |
PMID:23100158 PMID:31506784 PMID:36843289 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases cleavage |
ISO |
[alpha-Tocopherol co-treated with beta-ionone] results in increased activity of CASP3 protein beta-ionone results in increased expression of CASP3 protein modified form beta-ionone results in increased cleavage of CASP3 protein |
CTD |
PMID:17618090 PMID:23100158 PMID:31506784 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases cleavage |
ISO |
beta-ionone results in increased cleavage of CASP9 protein |
CTD |
PMID:36843289 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
beta-ionone results in decreased expression of CCND1 protein |
CTD |
PMID:15450939 PMID:31506784 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
beta-ionone results in decreased expression of CDK2 protein |
CTD |
PMID:15450939 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
beta-ionone results in decreased expression of CDK4 protein |
CTD |
PMID:15450939 PMID:31506784 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cryz |
crystallin zeta |
increases activity |
ISO |
beta-ionone results in increased activity of CRYZ protein |
CTD |
PMID:31506784 |
|
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
beta-ionone promotes the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of HMGCR mRNA] |
CTD |
PMID:20435455 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Lmnb1 |
lamin B1 |
decreases farnesylation |
ISO |
beta-ionone results in decreased farnesylation of LMNB1 protein |
CTD |
PMID:10203554 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
3-methyladenine inhibits the reaction [beta-ionone results in increased expression of and results in increased lipidation of MAP1LC3B protein]; beta-ionone results in increased expression of and results in increased lipidation of MAP1LC3B protein; STK11 protein affects the reaction [beta-ionone results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:36843289 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
beta-ionone results in increased phosphorylation of MAPK1 protein beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein modified form] |
CTD |
PMID:23268108 PMID:27226631 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK3 protein modified form] beta-ionone results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:23268108 PMID:27226631 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
beta-ionone inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] |
CTD |
PMID:23268108 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:23268108 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Olr59 |
olfactory receptor 59 |
multiple interactions |
ISO |
beta-ionone binds to and results in increased activity of OR51E2 protein |
CTD |
PMID:27226631 |
|
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
3-methyladenine inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein]; dorsomorphin inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein]; Hydroxychloroquine inhibits the reaction [beta-ionone results in increased cleavage of PARP1 protein]; STK11 protein affects the reaction [beta-ionone results in increased cleavage of PARP1 protein] |
CTD |
PMID:36843289 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] beta-ionone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] |
CTD |
PMID:23268108 PMID:31506784 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
beta-ionone inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] |
CTD |
PMID:23268108 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Stk11 |
serine/threonine kinase 11 |
increases phosphorylation multiple interactions |
ISO |
beta-ionone results in increased phosphorylation of STK11 protein STK11 protein affects the reaction [beta-ionone results in decreased expression of BCL2 protein]; STK11 protein affects the reaction [beta-ionone results in increased cleavage of PARP1 protein]; STK11 protein affects the reaction [beta-ionone results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:36843289 |
|
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
beta-ionone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; beta-ionone inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:23268108 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tyr |
tyrosinase |
increases expression |
ISO |
beta-ionone results in increased expression of TYR mRNA; beta-ionone results in increased expression of TYR protein |
CTD |
PMID:27226631 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|